Alan Crane

Alan Crane

Fondatore presso
Seismic Therapeutic, Inc.
62 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Alan L.
Crane
founded Momenta Pharmaceuticals, Inc. in 2001, where he worked as Chief Executive Officer & Director in 2006, Visterra, Inc. in 2007, where he worked as Chairman, Cerulean Pharma, Inc. in 2006, where he worked as Chairman from 2006 to 2014, Eagle Biologics, Inc. in 2013, where he worked as Chairman from 2014 to 2016, Pandion Operations, Inc. in 2017, where he is working as Director from 2017, and Seismic Therapeutic, Inc. in 2022, where he is working as Chairman from 2022.
Mr. Crane also founded Calorics Pharmaceuticals, where he worked as Chairman, Navitor Pharmaceuticals, Inc., where he worked as Chairman, President & Chief Executive Officer, and Zag Bio, Inc., where he is working as Chairman.
Mr. Crane also currently works at Dyno Therapeutics, Inc., as Executive Chairman, Combined Jewish Philanthropies of Greater Boston, Inc., as Director, XTuit Pharmaceuticals, Inc., as Director, KSQ Therapeutics, Inc., as Director, and Polaris Growth Management LLC, as Entrepreneur Partner from 2002.
Mr. Crane also formerly worked at Pandion Therapeutics, Inc., as Chairman, Sirtris Pharmaceuticals, Inc., as Director, Vaccinex, Inc., as Director from 2003 to 2019, Ocular Therapeutix, Inc., as Independent Director from 2009 to 2014, YourBio Health, Inc., as Director, Adnexus, as Director, Hydra Biosciences, Inc., as Director, T2 Biosystems, Inc., as Independent Director from 2007 to 2015, Millennium Pharmaceuticals, Inc., as Senior Vice President-Global Corporate Development from 1997 to 2002, ChemGenics Pharmaceuticals, Inc., as Vice President, Arthur D.
Little, Inc., as Consultant, The Boston Consulting Group, Inc., as Consultant, and DuPont Merck Pharmaceutical Co., as Marketing Executive.
Mr. Crane received his doctorate degree from Harvard Medical School, Masters Business Admin degree in 1992 from Harvard Business School, and undergraduate degree in 1985 and graduate degree in 1986 from Harvard College.

Posizioni attive di Alan Crane

SocietàPosizioneInizio
Investitore di Private Equity 01/01/2002
Direttore/Membro del Consiglio -
Fondatore 01/01/2017
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Presidente -
Fondatore 10/02/2022

Precedenti posizioni note di Alan Crane

SocietàPosizioneFine
PANDION THERAPEUTICS, INC. Presidente 01/04/2021
VACCINEX, INC. Direttore/Membro del Consiglio 14/05/2019
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Alan Crane

Formazione di Alan Crane

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

81

Relazioni di 1° grado

29

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private29

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Calorics Pharmaceuticals

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Technology Services

  1. Mercati
  2. Insiders
  3. Alan Crane